Cardio Diagnostics (CDIOW) Competitors $0.03 -0.01 (-28.17%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends CDIOW vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CTCXW, CELUW, CEROW, and CINGWShould you be buying Cardio Diagnostics stock or one of its competitors? The main competitors of Cardio Diagnostics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Carmell (CTCXW), Celularity (CELUW), CERo Therapeutics (CEROW), and Cingulate (CINGW). These companies are all part of the "biotechnology" industry. Cardio Diagnostics vs. 180 Life Sciences 60 Degrees Pharmaceuticals Alpha Tau Medical Anew Medical Apollomics BriaCell Therapeutics Carmell Celularity CERo Therapeutics Cingulate 180 Life Sciences (NASDAQ:ATNFW) and Cardio Diagnostics (NASDAQ:CDIOW) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, media sentiment, earnings, institutional ownership, community ranking, valuation, dividends and profitability. Does the MarketBeat Community believe in ATNFW or CDIOW? 180 Life Sciences and Cardio Diagnostics both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/ACardio DiagnosticsN/AN/A Is ATNFW or CDIOW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Cardio Diagnostics N/A N/A N/A Which has stronger earnings & valuation, ATNFW or CDIOW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/ACardio Diagnostics$39.14KN/AN/AN/AN/A Does the media favor ATNFW or CDIOW? In the previous week, 180 Life Sciences and 180 Life Sciences both had 1 articles in the media. 180 Life Sciences' average media sentiment score of 1.87 equaled Cardio Diagnostics'average media sentiment score. Company Overall Sentiment 180 Life Sciences Very Positive Cardio Diagnostics Very Positive SummaryCardio Diagnostics beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks. Ad ReticulateThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military.Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t Get Cardio Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for CDIOW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CDIOW vs. The Competition Export to ExcelMetricCardio DiagnosticsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$150.91M$5.15B$8.74BDividend YieldN/A3.64%5.18%4.08%P/E RatioN/A187.6766.3713.55Price / SalesN/A16,673.191,276.8487.67Price / CashN/A12.4639.7035.24Price / BookN/A7.886.475.93Net IncomeN/A-$20.05M$119.73M$225.73M7 Day PerformanceN/A7.83%-5.13%-1.34%1 Month PerformanceN/A11.90%-2.71%1.15%1 Year PerformanceN/A31.41%31.08%24.02% Cardio Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CDIOWCardio DiagnosticsN/A$0.03-28.2%N/A-63.6%$0.00$39,138.000.007Positive NewsGap UpATNFW180 Life SciencesN/A$0.01+30.8%N/A-32.5%$0.00N/A0.007Gap UpSXTPW60 Degrees PharmaceuticalsN/A$0.01flatN/A-26.0%$0.00$418,304.000.002Positive NewsDRTSWAlpha Tau MedicalN/A$0.20flatN/A-37.3%$0.00N/A0.0080News CoverageWENAWAnew MedicalN/A$0.04-0.3%N/AN/A$0.00N/A0.00N/AGap DownAPLMWApollomicsN/A$0.01flatN/A-81.2%$0.00N/A0.0059Short Interest ↓Positive NewsGap DownBCTXWBriaCell TherapeuticsN/A$0.24-19.2%N/A-81.4%$0.00N/A0.008Short Interest ↓Gap DownCTCXWCarmellN/A$0.11flatN/AN/A$0.00$12,320.000.009Positive NewsCELUWCelularityN/A$0.02-38.2%N/A+64.5%$0.00$33.52M0.00220Positive NewsGap UpCEROWCERo TherapeuticsN/A$0.01flatN/AN/A$0.00N/A0.008Short Interest ↓Positive NewsGap DownHigh Trading VolumeCINGWCingulateN/A$0.04-5.6%N/A+100.0%$0.00N/A0.0013Positive News Related Companies and Tools Related Companies ATNFW Competitors SXTPW Competitors DRTSW Competitors WENAW Competitors APLMW Competitors BCTXW Competitors CTCXW Competitors CELUW Competitors CEROW Competitors CINGW Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CDIOW) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardio Diagnostics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardio Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
